B. B. Duman Et Al. , "Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; A preliminary clinical study," JOURNAL OF BUON , vol.16, no.4, pp.759-764, 2011
Duman, B. B. Et Al. 2011. Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; A preliminary clinical study. JOURNAL OF BUON , vol.16, no.4 , 759-764.
Duman, B. B., Kara, B., KARA, İ. O., Demiryurek, H., & Aksungur, E., (2011). Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; A preliminary clinical study. JOURNAL OF BUON , vol.16, no.4, 759-764.
Duman, B. Et Al. "Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; A preliminary clinical study," JOURNAL OF BUON , vol.16, no.4, 759-764, 2011
Duman, B. B. Et Al. "Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; A preliminary clinical study." JOURNAL OF BUON , vol.16, no.4, pp.759-764, 2011
Duman, B. B. Et Al. (2011) . "Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; A preliminary clinical study." JOURNAL OF BUON , vol.16, no.4, pp.759-764.
@article{article, author={B. Bozkurt Duman Et Al. }, title={Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; A preliminary clinical study}, journal={JOURNAL OF BUON}, year=2011, pages={759-764} }